Global Pharmacokinetics Services Market by Drug Type (Small MoleculesLarge Molecules (Small Molecules, Large Molecules Biopharmaceuticals) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global pharmacokinetics services market was worth USD 652.8 million in 2017. It is expected to grow at an 8.3% CAGR during the forecast period. High drug attrition is due to poor pharmacokinetics (PK). Researchers are now embracing the trend to investigate novel moieties in PK at every stage of drug development to lessen concerns about high attrition.

Preclinical predictive pharmacokinetics/pharmacodynamics models are being used in different stages of clinical studies to identify potential bottlenecks in pharmaceutical development. This is mainly because PK studies allow for early identification of potential problems and assist with modifications to ensure that drug development challenges are minimized.

Over the last decade, PK has been a key component of drug discovery. Recognizing the importance of pharmacokinetics for pharmaceutical development, regulatory agencies and government are focusing their efforts to standardize pharmacokinetic protocols.

The regulatory requirements for clinical data pharmacokinetic have evolved over the years to address safety concerns of drug candidates. This has been a key factor in the reshaping of this market.

PK/PD analysis has been a key tool in drug development, allowing for rapid in-man studies and transitioning from preclinical to clinical studies. For various pharmaceuticals, it has been proven that in-vivo and in vitro human models can be used to study pharmacokinetic variability during clinical development.

Many companies have expanded their service offerings to keep their market edge. This is due to the gradual evolution of drug discovery into sound pharmacology. It is evident by the large number of companies that offer a wide range of services to support different phases of pharmaceutical development.

PK studies also interface with other functions of drug discovery, including toxicology, clinical pharmacology and marketing. This has resulted in a significant increase in the use of PK services within pharmaceutical industries.

Market growth will be slowed by certain limitations in in vitro PK studies. These include inability to use available protocols and experiments to predict the complete interactions between target and drug candidate.

Drug Type Insights

The market can be divided into two groups based on drug type. The small-molecule pharmacokinetic service focuses on the study of molecules with smaller atomic weights and drug metabolism. It also examines drug compounds in blood, urine, saliva and tissue using chromatographic techniques and spectroscopic assays.

Large-molecule pharmacokinetic methods include measurements of proteins, interactions and peptides, but mainly higher weight molecules such as IgE antibodies. They also include immunogenicity assays, Electrochemiluminescence (ECL) assays, and vaccine potency support as well as various other assays like ELISA.

Due to its high market penetration, PK analysis of small molecules accounted the largest share in revenue generation for 2017. Due to the expanding market for generics, this segment is expected grow at a rapid pace.

Although large molecules are expected to have a smaller market share than small molecules in the pharmacokinetics market, PK analysis for larger molecules is expected to grow faster. This is mainly due to the rising demand for biologics/biosimilars. CROs have invested in expanding their PK analysis portfolio for large moieties.

Regional Insights

North America was the country with the highest revenue share in 2017, due to the presence of many prominent pharmaceutical companies. There have been many strategic alliances between U.S.-based drug companies and CROs offering PK investigation services in this region. North America's dominance is due to the existence of a strong regulatory framework for drug development, including PKPD and toxicology studies.

Asia Pacific is the fastest-growing regional market due to CROs' constant business expansion. Asian countries have lower operating and manufacturing costs than developed nations. Asia Pacific is home to many potential subject organisms. These two factors will be driving factors in the expansion of pharmacokinetics services in Asian economies.

Market Share in Pharmacokinetics Services

Evotec AG, Certara, L.P., Pacific BioLabs, GVK Biosciences Private Limited, Shanghai Medicilon Inc., Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc., PAREXEL International Corporation, Eurofins Scientific, Inc., Frontage Labs, SGS SA, LGC Limited, and Creative Bioarray are some of the major service providers in this market.

These service providers have formed mutually beneficial partnerships across the globe with a number of prominent pharmaceutical and biopharmaceutical corporations. These service providers also make focused efforts to satisfy the needs of pharmaceutical developers and improve their market position.

Market Report Scope Pharmacokinetics Services

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2013 through 2025. Grand View Research segmented the global market for pharmacokinetics services on the basis drug type and location.

• The Drug Type Outlook (Revenue in USD Millions, 2013-2025)

  • Services for Small Molecules Pharmacokinetics

  • Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

• Regional Outlook (Revenue USD Million, 2013-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

  • Middle East & Africa

    • South Africa

These are the most frequently asked questions about this report

b. Global pharmacokinetics market size was USD 0.78 billion in 2019, and is forecast to grow to USD 0.85 billion by 2020.

b. Global pharmacokinetics markets are expected to grow at a compound annual rate of 8.7% between 2020 and 2025, reaching USD 1.24 Billion by 2025.

b. With a 77% share in 2019, small molecules dominated the pharmacokinetics industry. This is due to the increasing popularity of generics and their high penetration.

b. Evotec AG, Certara, L.P., Pacific BioLabs, Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc., PAREXEL International Corporation, Eurofins Scientific, Inc., Frontage Labs, SGS SA, LGC Limited, and Creative Bioarray are some of the key players in the pharmacokinetics industry.

b. Market growth is driven by two key factors: rising concerns about drug attrition rates among drug developers, and a significant increase in the number of clinical trial study programs.

Up Market Research published a new report titled “Pharmacokinetics Services Market research report which is segmented by Drug Type (Small MoleculesLarge Molecules (Small Molecules, Large Molecules Biopharmaceuticals), By Players/Companies Inc; PAREXEL International Corporation; Eurofins Scientific, Inc; Frontage Labs; SGS SA; LGC Limited; and Creative Bioarray, LP; Pacific BioLabs; Pharmaceutical Product Development, LLC; Charles River Laboratories International, Evotec AG; Certara”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Pharmacokinetics Services Market Report Segments:

The market is segmented by Drug Type (Small MoleculesLarge Molecules (Small Molecules, Large Molecules Biopharmaceuticals).

Pharmacokinetics Services Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pharmacokinetics Services Market

Overview of the regional outlook of the Pharmacokinetics Services Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Pharmacokinetics Services Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Pharmacokinetics Services Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Small Molecules

                2. Large Molecules Biopharmaceuticals

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pharmacokinetics Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Pharmacokinetics Services Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.